期刊
JOURNAL OF NUCLEAR MEDICINE
卷 50, 期 2, 页码 239-249出版社
SOC NUCLEAR MEDICINE INC
DOI: 10.2967/jnumed.108.056655
关键词
response assessment; surrogate biomarker; functional/molecular imaging; volumetric CT; lung cancer
This article addresses the current status of quantitative imaging as a surrogate biomarker for the assessment of tumor response to therapy with non-small cell lung cancer as an example. In addition, the article discusses the limitations of conventional response criteria in the new era of molecular-targeted agent for cancer treatment; the increasing need for more accurate and early response-assessment methods, particularly for volumetric CT; new tumor-specific radiotracers and molecular imaging technologies; and the future applications of molecular imaging with PET for studying various features of cancer metabolism, endocrine status, hypoxia, and oncofetal and differentiation antigens.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据